Background Optimal drug treatment for patients with resistant hypertension is undefined. We
aimed to test the hypotheses that resistant hypertension is most often caused by excessive …

Background: Glucocorticoids have adverse systemic effects, including obesity, hypertension,
and hyperglycemia, that may predispose to cardiovascular disease. The effect of …

Background Intensive insulin treatment effectively delays the onset and slows the progression
of microvascular complications in insulin-dependent diabetes mellitus (IDDM). Variable …

Aims To evaluate the patterns and predictors of adherence in all patients with Type 2 diabetes
in the community receiving treatment with a single oral hypoglycaemic drug. In particular, …

Aims The influence of socio‐economic status on the prevalence of Type 1 and Type 2 diabetes
mellitus, and on obesity, was explored using routinely collected healthcare data for the …

Background Vascular endothelial dysfunction may predict future atherosclerosis. Hence, an
antihypertensive agent that reverses endothelial dysfunction and lowers blood pressure …

Context: For patients on T 4 replacement, the dose is guided by serum TSH concentrations,
but some patients request higher doses due to adverse symptoms. Objective: The aim of the …

Background Studies have suggested that evening dosing with antihypertensive therapy
might have better outcomes than morning dosing. The Treatment in Morning versus Evening (…

Aldosterone is well recognized as a cause of sodium reabsorption, water retention, and
potassium and magnesium loss; however, it also produces a variety of other actions that lead to …

Objectives: To investigate patterns of self monitoring of blood glucose concentration in diabetic
patients who use insulin and to determine whether frequency of self monitoring is related …